Event
FDA Convening
RISE to the Challenge: Statistical Considerations for Rare Disease Clinical Investigations
WASHINGTON, DC
This public workshop, co-convened by Duke Margolis and the FDA Rare Disease Innovation Hub, will...
Read MoreEvent
Accountable Care in 2027: Building the Evidence Base and Driving Practical Policy Solutions
WASHINGTON, DC
As 2027 approaches, accountable care is entering a new phase of evolution. While the model has...
Read More